In particular, CNP and its receptor natriuretic peptide receptor-B (NPR-B) signaling is a pivotal stimulator of endochondral bone growth [6, 7], and CNP or its analogue could be one of the most expecting therapeutic approaches to short statue patients, such as achondroplasia [8]. The gene discussed is NPR2; the disease is achondroplasia.